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Abstract
Identifying patients at-risk for HIV infection, such as men who have sex with men (MSM), is an 
important step in providing HIV testing and prevention interventions. It is unknown how primary 
care providers (PCPs) assess MSM status and related HIV-risk factors. We analyzed data from a 
panel-derived web-based survey for healthcare providers conducted in 2014 to describe how PCPs 
in the U.S. determined their patients' MSM status. We calculated adjusted prevalence ratios (aPR) 
and 95% confidence intervals (CI) to describe PCP characteristics associated with systematically 
determining MSM status (i.e., PCP used “a patient-completed questionnaire” or “routine verbal 
review of sex history”). Among the 1008 PCPs, 56% determined MSM status by routine verbal 
review of sexual history; 41% by patient disclosure; 39% by questions driven by symptoms/
history; 23% by using a patient-completed questionnaire, and 9% didn't determine MSM status. 
PCPs who systematically determined MSM status (n = 665; 66%) were more likely to be female 
(aPR = 1.16, CI = 1.06–1.26), to be affiliated with a teaching hospital (aPR = 1.15, CI = 1.06–
1.25), to routinely screen all patients aged 13–64 for HIV (aPR = 1.29, CI = 1.18–1.41), and to 
estimate that 6% or more of their male patients are MSM (aPR = 1.14, CI = 1.01–1.30). The 
majority of PCPs assessed MSM status and HIV risk factors through routine verbal reviews of 
sexual history. Implementing a systematic approach to identify MSM status and assess risk may 
allow PCPs to identify more patients needing frequent HIV testing and other preventive services, 
while mitigating socio-cultural barriers to obtaining such information.
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1. Introduction
In 2006, the Centers for Disease Control and Prevention (CDC) recommended routine HIV 
screening in all healthcare settings for patients between the ages of 13 and 64, as well as 
repeat screening at least once a year for patients at high risk for HIV infection, a group that 
includes sexually active gay, bisexual, and other men who have sex with men (collectively 
referred to as MSM) (Branson et al., 2006). In April 2013, the United States Preventive 
Services Task Force (USPSTF) issued updated recommendations on routine testing for HIV 
(U.S. Preventive Services Task Force, 2013), which were largely consistent with the 2006 
CDC HIV testing recommendations, and suggested that at least annual HIV testing for very 
high-risk groups, such as MSM, was a “reasonable approach”.
Despite these recommendations, and several reports indicating the acceptability of routine 
testing among the public (Christopoulos et al., 2012; Hack et al., 2013; Harmon et al., 2014; 
Jover-Diaz et al., 2012; Valenti et al., 2012), universal HIV testing has not been widely 
implemented in healthcare settings (Centers for Disease Control and Prevention, 2012a, 
2013a; Hoover et al., 2013; McNaghten et al., 2013; Rizza et al., 2012), and many MSM are 
still not being screened frequently enough (Centers for Disease Control and Prevention, 
2016). MSM who report being offered an HIV test by their doctor are more likely to disclose 
male-to-male sexual activity (Wall et al., 2010). Primary care providers (PCPs) who know 
their patients' sexual orientation are more likely to discuss sexual activity and risk behavior; 
however, many PCPs do not inquire about the sexual orientation of their patients (Petroll and 
Mosack, 2011). Given that sexual orientation or identity is not necessarily correlated with 
sexual behavior, it might be more accurate for PCPs to assess sexual behaviors among their 
patients. However, previous reports have indicated that healthcare providers feel 
uncomfortable discussing sexual behaviors in what they perceive to be low HIV prevalence 
settings, or cite a lack of time as a barrier to having these discussions with their patients 
during the office visit (Carter et al., 2014; Lanier et al., 2014; White et al., 2015). These 
barriers could potentially be overcome by the use of a systematic approach, such as a patient 
questionnaire, that does not require targeting specific clients or waiting for a patient to 
initiate disclosing their sexual orientation or HIV-associated risk factors to their physician. 
However, there are currently few tools to help clinicians assess their patients' sexual history 
and risk for HIV (Centers for Disease Control and Prevention, 2017; Knight and Jarrett, 
2015; Lanier et al., 2014), and little is known about how widely they are used in health care 
settings, specifically in primary care settings in the United States. It is unknown what 
methods, if any, U.S. PCPs are using to assess their patient's MSM status.
The purpose of this analysis was: 1) to assess which methods U.S. PCPs use to determine 
which patients are MSM; 2) to characterize PCPs who identify MSM using a systematic 
approach; and 3) to describe which HIV risk factors PCPs assess among MSM patients.
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2. Methods
2.1. Study sample
We analyzed data from DocStyles 2014, a web-based survey of U.S. healthcare providers 
(PCPs, pediatricians, obstetrician/gynecologists, nurse practitioners) conducted by Porter 
Novelli Public Services, a public relations firm that specializes in health and social 
marketing. The PCP sample was drawn from SERMO/WorldOne's Global Medical Panel, a 
marketing panel that in 2014 included over 270,000 physicians and over 1,000,000 medical 
professionals in the U.S. (Porter Novelli, 2014) The PCP sample included healthcare 
providers who identified as Family or General Practitioners, or as Internists. To reach a 
predetermined quota of 1000 PCPs, a random sample of 2512 health professionals, which 
included 1353 PCPs, was selected from the SERMO database to receive an invitation to 
participate in the web-based survey.
PCP respondents were screened to include only providers who worked in an individual, 
group, or hospital practice, and who actively saw patients in the U.S. for at least three years 
preceding the survey. The survey was conducted from June 18, 2014 to June 30, 2014. PCP 
respondents were paid an honorarium of $69 for completing the survey. Completed survey 
responses were obtained from 1008 PCPs, representing a 74.5% response rate.
CDC obtained a license to access the results dataset of the DocStyles 2014 survey from 
Porter Novelli. The analysis was exempted from CDC institutional review board approval as 
no individual identifiers were included in the dataset provided to CDC.
2.2. Measures
2.2.1. Outcome variable—The main outcome variable for this study was whether PCPs 
used a systematic approach to assess MSM status among their patients, and was defined 
using the question: “How do you typically determine if a male patient has male sex partners? 
Select all that apply.” PCPs using systematic methods were those who said they determined 
if their patient is MSM by either the use of a questionnaire completed by the patient, or 
through a routine verbal review of sexual history. PCPs not using systematic methods 
included those who indicated they do not assess MSM status, or those who say they could 
determine MSM status from questions driven by symptoms or history and/or from patient 
disclosure.
2.2.2. Independent variables—Additional demographic and health-related covariates 
included age category (27–29, 30–39, 40–49, 50–59, and 60 or older); gender (male or 
female); race/ethnicity (non-Hispanic white, non-Hispanic black/African American, non-
Hispanic Asian, non-Hispanic other/multiple race, and Hispanic); number of years 
practicing medicine (3–9, 10–19, 20 or more); whether PCP is affiliated with a teaching 
hospital (yes or no); main work setting (individual outpatient practice, group outpatient 
practice, or inpatient practice); use of electronic health records in practice (yes or no); 
average number of patient visits per week (< 100 or 100 or more); PCP-perceived financial 
situation of the majority of their patients (very poor/lower middle class, middle class, or 
affluent/upper middle class); PCP-estimated proportion of patients who are MSM (< 1%, 1–
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5%, 6% or more, or “I don't know”); whether PCP routinely screens all patients 13–64 for 
HIV (yes or no); PCP beliefs about the most effective HIV prevention approach (risk-based 
HIV screening is the most effective approach, HIV screening for all persons age 13 to 64 is 
the most effective approach, or HIV screening is a public health concern and not an issue in 
my clinical practice); and if PCP has diagnosed patients with HIV in the past 12 months (yes 
or no).
To describe the HIV-risk behaviors assessed by PCPs among their MSM patients, PCPs were 
asked: “Which of the following characteristics do you assess among your male patients who 
have sex with men? Select all that apply.” Response options included: patient's self-reported 
HIV status, frequency of HIV testing, number of male sex partners, new male sex partners 
since last HIV test, number of HIV-infected male sex partners, type of sex (e.g., receptive 
anal sex, insertive anal sex, oral sex, etc.), any recent history or current symptoms of 
sexually transmitted infections, recreational drug use, whether patient has sex without a 
condom, sex while using drugs or alcohol, and exchanged sex for money or drugs. 
Respondents could also indicate they did not assess any of the above.
2.2.3. Statistical analysis—All analyses were conducted using SAS software (version 
9.3, SAS Institute, Inc., Cary, NC). We performed bivariate analyses of demographic PCP 
characteristics, and practice-related factors associated with using a systematic method of 
identifying MSM, with the chi-square test. Crude prevalence ratios, based on Poisson 
regression models with a robust standard error with generalized estimating equation 
procedures, were used in bivariate analyses to test for overall differences in the use of 
systematic methods to identify MSM among the levels of independent study variables. We 
used a multivariable Poisson model to estimate adjusted prevalence ratios. The model 
included significant covariates as determined by chi-square tests, as well as race/ethnicity, 
regardless of the level of statistical significance because of its potential importance to the 
model. We used the backward elimination approach to remove covariates from the model 
with a p-value > 0.15. We present the unadjusted and adjusted prevalence ratios with 95% CI 
for the final model. For all analyses, we considered a p-value of 0.05 or less statistically 
significant.
3. Results
3.1. Methods for determining MSM status
When PCPs were asked how they assessed MSM status among their male patients (Fig. 1), 
more than half reported using “routine verbal review of sexual history” and less than a 
quarter reported “from a questionnaire completed by patient”. Combining these two resulted 
in 665 PCPs (66%) reporting the use of at least one systematic method to identify MSM 
patients and 343 (34%) PCPs not using a systematic method at all, which included 90 (9%) 
PCPs who indicated they do not routinely assess MSM status among their patients.
3.2. PCP demographics and practice characteristics
PCP demographics and practice characteristics are summarized in Table 1. The majority of 
PCP respondents were male (73%), with an average age of 46 (SD = 10), and on average had 
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been practicing medicine for 15.3 years (SD = 8.5). By race/ethnicity, 57% were white, 28% 
were Asian, and 2% were black or African American. Most PCPs (69%) worked at a group 
outpatient practice, 51% were affiliated with a teaching hospital, 68% saw an average of 100 
patients or more per week, 89% used electronic health records in their practice, and 46% 
considered the financial situation of the majority of their patients as affluent or upper middle 
class.
The majority of PCPs (72%) did not routinely screen all of their patients aged 13–64 for 
HIV and 49% had not diagnosed HIV among their patients in the past 12 months. 
Concerning PCP beliefs on the most effective approach for HIV prevention, 63% indicated 
risk-based screening was most effective, 30% indicated universal screening, and 7% 
considered HIV screening as a public health concern and not an issue in their clinical 
practice. PCPs were asked to estimate the proportion of MSM among their patient 
population. Only 7% indicated that they did not know what proportion of their male patients 
were MSM and 25% estimated that > 5% of their male patients were MSM.
3.3. PCP characteristics by method used to determine MSM status
We then investigated which PCP characteristics were associated with using a systematic 
method to determine MSM status (Table 1). Significant associations were found by gender, 
number of years practicing medicine, being affiliated with a teaching hospital, electronic 
health records used in practice, financial situation of majority of patients, estimated 
proportion of MSM patients, routinely screening all patients aged 13–64, beliefs about the 
most effective HIV prevention approach, and having diagnosed patients with HIV in the past 
12 months.
3.4. PCP characteristics independently associated with PCPs who systematically identify 
MSM
The results of the bivariate and the multivariable model are presented in Table 2. In the 
multivariable model several factors were significantly associated with systematically 
identifying MSM patients. PCPs who used a systematic method were 16% more likely to be 
female physicians (95% CI = 1.06–1.26) compared to male PCPs. Compared to PCPs not 
affiliated with a teaching hospital, PCPs with teaching hospital privileges were 15% more 
likely to use a systematic method to identify MSM (95% CI = 1.06–1.25).
PCPs who routinely screen for HIV were 29% more likely to use a systematic method than 
PCPs who do not routinely screen for HIV (95% CI = 1.18–1.41). PCPs who estimated their 
MSM patient population to be 6% or more were 14% more likely to use a systematic 
assessment method (95% CI = 1.01–1.30) compared to PCPs with an estimated MSM 
patient population of < 1%.
In contrast, PCPs who believed HIV screening is a public health concern and not an issue for 
their own clinical practice and PCPs who didn't know the proportion of MSM among their 
patients were less likely to use a systematic method to asses MSM status.
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3.5. HIV-related factors assessed by PCPs
The most common HIV-related factors assessed by all PCPs among their MSM patients 
(Table 3) were the patient's self-reported HIV status reported by 62% of PCPs, followed by 
frequency of HIV testing (58%), the number of male sex partners (57%), if the patient had 
new male sex partners since last HIV test (57%) and the number of HIV–infected male 
partners (54%). For all risk factors assessed, the percent of PCPs using a systematic method 
who said they assessed the risk factor was significantly higher than the percent of PCPs not 
using a systematic method.
4. Discussion
The findings of this study provide evidence that a majority of PCPs actively try to determine 
whether their male patients have sex with men, and to discuss HIV risk factors and sexual 
histories with their MSM patients using systematic methods, mostly from a routine verbal 
review, as opposed to waiting on patient disclosure or through questions driven by symptoms 
or medical history. However, it remains unclear if this active determination of MSM status 
among their patients was applied consistently to every patient. That not all PCPs are actively 
determining the MSM status of some or all of their patients aligns with previous literature 
indicating that some PCPs feel discomfort discussing sexual health (Carter et al., 2014), 
report lack of time to discuss sexual health issues with patients (Carter et al., 2014; Lanier et 
al., 2014; White et al., 2015), or feel uncertain on how to approach sexual health with MSM 
patients (Mayer, 2014; Underhill et al., 2015; Wolitski and Fenton, 2011). Relying on the 
patient to initiate this discussion is not an effective approach; reports indicate that only 61–
70% of MSM tell their sexual orientation to their PCPs without prompting (Bernstein et al., 
2008; Petroll and Mosack, 2011), while another study indicates willingness among many 
participants to disclose same-sex behavior when asked by their PCPs (Underhill et al., 
2015).
In our study, PCP gender, practices (i.e., routine screening for HIV, affiliations with teaching 
hospitals), and perceptions (i.e., beliefs about most effective HIV prevention approach or 
perceived proportion of MSM patients) were independently associated with using a 
systematic method, which highlights how societal and cultural norms might hinder or 
facilitate the assessment of MSM status. Our findings complement previous studies that 
suggest female providers are more aware of the sexual orientation of their MSM patients 
(Petroll and Mosack, 2011) and are more likely to favor routine HIV testing (Arbelaez et al., 
2012). Providers have also stated that PCP knowledge about the rationale for routine HIV 
testing could facilitate testing (White et al., 2015). Therefore, it may be that the associations 
observed between using a systematic method to assess MSM status, and routine screening 
practices or affiliations with teaching hospitals, are due to increased knowledge about HIV 
testing and risk behaviors among these providers.
Implementing a more objective systematic approach, such as a patient questionnaire to 
review sexual history and HIV risk factors, which was used by less than a quarter of PCPs in 
our study, might reduce the impact of individual-level factors on assessing MSM status 
among patients. We found that most PCPs using a systematic method assessed MSM status 
and HIV risk factors through routine verbal reviews of sexual history (more than half of our 
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sample); however, due to the unstructured nature of verbal reviews, the HIV risk factors that 
are reportedly assessed by our PCPs are not necessarily assessed consistently among all their 
MSM patients. Using a patient questionnaire as part of a routine annual or biannual visit 
might prove useful to consistently ask and collect such information from all patients. With 
the incorporation of electronic health records in healthcare settings, a patient questionnaire 
to properly assess risk for HIV/STD acquisition in its electronic format might be an 
approach that medical providers could consider. There are currently several sexual history 
taking toolkits and educational materials that aim to help physicians with this task (Centers 
for Disease Control and Prevention, 2005; National LGBT Health Education Center 
(Fenway Institute) and the National Association of Community Health Centers, 2015; 
Sweet, 2017) and could be a good starting point to implement systematic ways of assessing 
MSM status and HIV risk factors.
Using a systematic approach to identify MSM in the primary care practice would then be a 
facilitator for identifying patients who would benefit from at least annual HIV screening 
(Branson et al., 2006). PCPs may act as facilitators and encouragers of routine testing among 
sexually active MSM, (Owczarzak et al., 2011) especially in non-judgmental interactions 
during doctor's visits (Knight and Jarrett, 2015; Mimiaga et al., 2007). Our data also 
indicated that more than half of PCPs reported assessing common HIV risk factors and 
behaviors among their MSM patients. Therefore, when clinicians are able to identify MSM 
patients and assess their risk, they can explain the biomedical options currently available for 
them beyond HIV screening, such as post-exposure prophylaxis (Kuhar et al., 2013), pre-
exposure prophylaxis (Centers for Disease Control and Prevention, 2011, 2012b, 2013b), 
STI screening and treatment (Workowski and Berman, 2010; Workowski et al., 2015), 
vaccinations (such as human papilloma virus or hepatitis vaccines), and recommended 
behavioral interventions, such as HIV prevention or risk-reduction counseling (Centers for 
Disease Control and Prevention, 2001).
4.1. Limitations
The current analysis had several limitations. First, the findings result from an online panel 
survey and may not be generalizable to all U.S.-based PCPs. However, in addition to 
achieving a high response rate, the sampling methodology used by SERMO rendered a PCP 
sample that was comparable to U.S. physicians in gender, age, and U.S. region, as estimated 
by the American Medical Association (Porter Novelli, 2014). Second, measures used in the 
analysis are self-reported by the respondents and are, therefore, subject to recall and social 
desirability bias. Providers might be reporting what they would like to do rather than what 
they are actually doing. In one study, only 14% of MSM reported that their PCPs asked them 
about their sexual orientation while another 14% indicated their PCP guessed (Petroll and 
Mosack, 2011). Third, the frequency of the administration of “routine verbal review” and 
“patient questionnaires” was not assessed therefore we were not able to evaluate if PCP 
determined MSM status of all their male patients or just of a portion. PCPs may have 
reported the method used in those cases when they find out a patient is MSM, rather than 
noting their general approach to determining MSM status among male patients. This 
limitation should be considered in the application of the findings of the current study. 
Finally, no causal associations can be inferred given the cross-sectional design of the survey. 
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Also, additional research might be needed to define the patient's role in disclosure of sexual 
identity and sexual behaviors in the primary care setting as it was beyond the scope of this 
study.
5. Conclusions
The findings of this analysis indicate that more than half of PCPs assess the same-sex sexual 
behavior of their male patients using a systematic approach. PCP gender, perceptions, and 
practices may hinder the systematic assessment of MSM status. Implementing a systematic 
approach to assess sexual and HIV-related risk history, such as a patient questionnaire, may 
allow PCPs to identify patients needing more frequent HIV/STI testing or other preventive 
services while mitigating socio-cultural barriers to obtaining such information.
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Fig. 1. 
Methodsa used by 1008 PCPS to determine MSM status of their patients, DocStyles 2014.
Abbreviations: PCPs, primary care providers; MSM, men who have sex with men.
aRespondents could select more than one method.
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Table 3
HIV risk factors and behaviors assessed by PCPs among their MSM patients by use of a systematic method, 
DocStyles 2014.
HIV risk factors/behaviorsa All PCPs
n (%)
PCPs using SM
n (%)
PCPs not using SM
n (%)
p-value
Patient's self-reported HIV status 625 (62.0) 450 (67.7) 175 (51.0) < 0.001
Frequency of HIV testing 583 (57.8) 427 (64.2) 156 (45.5) < 0.001
Number of male sex partners 577 (57.2) 436 (65.6) 141 (41.1) < 0.001
New male sex partners since last HIV test 569 (56.5) 429 (64.5) 140 (40.8) < 0.001
Number of HIV-infected male sex partners 548 (54.4) 420 (63.2) 128 (37.3) < 0.001
Type of sex (e.g. receptive anal sex, insertive anal sex, oral sex) 478 (47.4) 381 (57.3) 97 (28.3) < 0.001
Whether patient has sex without a condom 465 (46.1) 376 (56.5) 89 (26.0) < 0.001
Recreational drug use 377 (37.4) 302 (45.4) 75 (21.9) < 0.001
Sex while using drugs or alcohol 319 (31.7) 248 (37.3) 71 (20.7) < 0.001
Exchange sex for money or drugs 269 (26.7) 218 (32.8) 51 (14.9) < 0.001
Any recent history or current symptoms of STI 184 (18.3) 152 (22.9) 32 (9.3) < 0.001
I do not assess any of the above 92 (9.1) 20 (3.0) 72 (21.0) < 0.001
TOTAL 1008 665 343
Abbreviations: PCPs, primary care providers; SM, systematic method.
P-values smaller than 0.05 are indicated in bold.
a
Respondents could select more than one HIV risk factor/behavior.
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